Elekta shared on LinkedIn:
“We are expanding adaptive radiotherapy across our portfolio with new capabilities for Elekta Harmony and Elekta Prostate Guideway.
Now spanning MR- and CT-guided radiotherapy, Gamma Knife radiosurgery and image-guided brachytherapy, our adaptive offering gives clinicians greater flexibility to select the imaging and workflow best suited to the patient, indication and clinical need.
Read more in The Press Release.
Product availability and regulatory status vary by market.
Prostate Guideway is pre-commercial and pending U.S. FDA 510(k) clearance and EU CE marking.”
You can also read: Elekta and Siemens Healthineers Sign Letter of Intent to Advance Interoperability Across Oncology Platforms
